NCT07608094 The Treatment Outcomes of Cesarean Scar Pregnancy
| NCT ID | NCT07608094 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Women's Hospital School Of Medicine Zhejiang University |
| Condition | Cesarean Scar Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 82 participants |
| Start Date | 2025-08-13 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 82 participants in total. It began in 2025-08-13 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes
Eligibility Criteria
Inclusion Criteria: 1. Women over 18 years old with a history of cesarean section 2. Ultrasound diagnosis of cesarean scar pregnancy 3. No severe internal or external diseases, such as liver disease, kidney disease, cardiovascular disease, cerebrovascular disease, etc., and able to tolerate surgery Exclusion Criteria: 1. Women under the age of 18 2. CSP patients who have received treatment in other hospitals
Contact & Investigator
xiuxiu jiang
PRINCIPAL INVESTIGATOR
women's hospital school of medicine Zhejiang uni
Frequently Asked Questions
Who can join the NCT07608094 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cesarean Scar Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07608094 currently recruiting?
Yes, NCT07608094 is actively recruiting participants. Contact the research team at jaingxiuxiu0418@zju.edu.cn for enrollment information.
Where is the NCT07608094 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT07608094 clinical trial?
NCT07608094 is sponsored by Women's Hospital School Of Medicine Zhejiang University. The principal investigator is xiuxiu jiang at women's hospital school of medicine Zhejiang uni. The trial plans to enroll 82 participants.